Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
11.22
-0.42 (-3.61%)
Jul 18, 2025, 4:00 PM - Market closed
Avanos Medical Market Cap
Avanos Medical has a market cap or net worth of $518.86 million as of July 18, 2025. Its market cap has decreased by -42.68% in one year.
Market Cap
518.86M
Enterprise Value
562.76M
1-Year Change
-42.68%
Ranking
Category
Stock Price
$11.22
Market Cap Chart
Since October 21, 2014, Avanos Medical's market cap has decreased from $1.91B to $518.86M, a decrease of -72.81%. That is a compound annual growth rate of -11.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 538.30M | -26.42% |
| Dec 31, 2024 | 731.60M | -29.74% |
| Dec 29, 2023 | 1.04B | -17.24% |
| Dec 30, 2022 | 1.26B | -24.69% |
| Dec 31, 2021 | 1.67B | -23.88% |
| Dec 31, 2020 | 2.19B | 35.87% |
| Dec 31, 2019 | 1.62B | -23.97% |
| Dec 31, 2018 | 2.12B | -1.78% |
| Dec 29, 2017 | 2.16B | 25.31% |
| Dec 30, 2016 | 1.73B | 10.83% |
| Dec 31, 2015 | 1.56B | -26.40% |
| Dec 31, 2014 | 2.12B | 10.90% |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 683.63B |
| Johnson & Johnson | 392.14B |
| AbbVie | 338.09B |
| Novo Nordisk | 292.40B |
| UnitedHealth Group | 261.32B |
| Novartis AG | 224.54B |
| AstraZeneca | 214.46B |
| Abbott Laboratories | 209.67B |